|
|
Volumn 31, Issue 20, 2013, Pages
|
|
Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME;
ALPHA INTERFERON;
B RAF KINASE;
CD103 ANTIGEN;
CD22 ANTIGEN;
CLADRIBINE;
CYCLIN D1;
GLYCOPROTEIN P 15095;
IMMUNOGLOBULIN LAMBDA CHAIN;
INTERLEUKIN 2 RECEPTOR ALPHA;
PENTOSTATIN;
RITUXIMAB;
TRANSCRIPTION FACTOR PAX5;
VEMURAFENIB;
ANTINEOPLASTIC AGENT;
BRAF PROTEIN, HUMAN;
INDOLE DERIVATIVE;
SULFONAMIDE;
ADULT;
ARTHRALGIA;
ARTICLE;
B LYMPHOCYTE;
BONE MARROW BIOPSY;
CANCER PATIENT;
CANCER SURGERY;
CASE REPORT;
CELL INFILTRATION;
DNA SEQUENCE;
DRUG RESPONSE;
DRUG WITHDRAWAL;
FATIGUE;
FLOW CYTOMETRY;
GENE MUTATION;
HAIRY CELL LEUKEMIA;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
LEUKOCYTE COUNT;
MOOD DISORDER;
MUTANT;
NEUTROPENIA;
NEUTROPHIL COUNT;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
SPLENECTOMY;
STAINING;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
BLOOD ANALYSIS;
DOSE RESPONSE;
FOLLOW UP;
GENE EXPRESSION REGULATION;
GENETICS;
MALE;
MUTATION;
NEEDLE BIOPSY;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
BLOOD CHEMICAL ANALYSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FOLLOW-UP STUDIES;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IMMUNOHISTOCHEMISTRY;
INDOLES;
LEUKEMIA, HAIRY CELL;
MALE;
MUTATION;
PROTO-ONCOGENE PROTEINS B-RAF;
SEVERITY OF ILLNESS INDEX;
SULFONAMIDES;
TREATMENT OUTCOME;
|
|
EID: 84883875497
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.45.7739 Document Type: Article |
|
Times cited : (57)
|
|
References (6)
|
